Page last updated: 2024-11-05

thiotepa and Ataxia Telangiectasia

thiotepa has been researched along with Ataxia Telangiectasia in 1 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Ataxia Telangiectasia: An autosomal recessive inherited disorder characterized by choreoathetosis beginning in childhood, progressive CEREBELLAR ATAXIA; TELANGIECTASIS of CONJUNCTIVA and SKIN; DYSARTHRIA; B- and T-cell immunodeficiency, and RADIOSENSITIVITY to IONIZING RADIATION. Affected individuals are prone to recurrent sinobronchopulmonary infections, lymphoreticular neoplasms, and other malignancies. Serum ALPHA-FETOPROTEINS are usually elevated. (Menkes, Textbook of Child Neurology, 5th ed, p688) The gene for this disorder (ATM) encodes a cell cycle checkpoint protein kinase and has been mapped to chromosome 11 (11q22-q23).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ivanova, IuE1
Bochkov, NP1
Iakovenko, KN1

Other Studies

1 other study available for thiotepa and Ataxia Telangiectasia

ArticleYear
[Effect of thiophosphamide on the frequency of chromosome aberrations in cells heterozygous for ataxia-telangiectasia].
    Biulleten' eksperimental'noi biologii i meditsiny, 1980, Volume: 89, Issue:7

    Topics: Ataxia Telangiectasia; Cells, Cultured; Chromosome Aberrations; Heterozygote; Humans; Lymphocytes; T

1980